Search Results

Celera Motion, a leader in precision motion component and sub-system solutions and a business unit of Novanta Corporation announces the addition of Capitan Series to their line of premium performance Ingenia servo drives.

Ms. Ordonez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and RainDance Technologies.

ACELYRIN, INC. announced the appointment of Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications.

enGene Holdings Inc., a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer, announced the election of Paul Hastings and Wouter Joustra as new members of its Board of Directors at the Company’s 2024 annual meeting of shareholders.

Diversified biotechnology company CCM Biosciences announced the launch of its business unit CCM 5Prime Sciences focused on the development and application of proprietary technology in the domain of DNA biotechnology.

Think Bioscience (“Think”), a Boulder-based synthetic biology company focused on developing small-molecule therapeutics that target “undruggable” proteins, has appointed Wendy Young, Ph.D., to its Scientific Advisory Board.

Rapport Therapeutics, Inc today announced the appointment of Cheryl Gault as Chief Operating Officer and Wendy Young, Ph.D., as a member of its Scientific Advisory Board.

The global genetic analysis market was evaluated at USD 10.55 billion in 2023 and is expected to attain around USD 23.60 billion by 2033

Acurex Biosciences Corporation, a biopharmaceutical company with a mission to stop neurodegeneration before it begins, announces the appointment of renowned biopharmaceutical industry leader Dr. Robert Booth to its Board of Directors.